|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA06000261
|
trans-13-methyltetradec-2-enal
|
(2E)-13-methyltetradec-2-enal
|
FAL 15:1
|
C15H28O
|
224.214015
|
|
LMFA01050425
|
Tetrapedic acid B
|
3R,7R-dihydroxy-docosanoic acid
|
FA 22:0;O2
|
C22H44O4
|
372.323961
|
|
LMFA01050425
|
Tetrapedic acid B
|
3R,7R-dihydroxy-docosanoic acid
|
FA 22:0;O2
|
C22H44O4
|
372.323961
|
|
LMFA01090119
|
Ethyl 18-bromooctadec-17-en-5,7,15-triynoate
|
Ethyl 18-bromo-17E-octadecen-5,7,15-triynoate
|
|
C20H25BrO2
|
376.103790
|
|
LMFA01090119
|
Ethyl 18-bromooctadec-17-en-5,7,15-triynoate
|
Ethyl 18-bromo-17E-octadecen-5,7,15-triynoate
|
|
C20H25BrO2
|
376.103790
|
|
LMFA05000665
|
heptane-1,2,3-triol
|
heptane-1,2,3-triol
|
FOH 7:0;O2
|
C7H16O3
|
148.109945
|
|
LMFA01090140
|
3,3-diiodoacrylic acid
|
3,3-diiodo-2-propenoic acid
|
|
C3H2I2O2
|
323.814409
|
|
LMFA01090140
|
3,3-diiodoacrylic acid
|
3,3-diiodo-2-propenoic acid
|
|
C3H2I2O2
|
323.814409
|
|
LMFA11000711
|
2,3,4-Trimethyl-pentane
|
2,3,4-Trimethyl-pentane
|
|
C8H18
|
114.140850
|
|
LMFA11000217
|
11-Methylpentacosane
|
11-Methylpentacosane
|
|
C26H54
|
366.422551
|
|
LMFA11000682
|
2,6,11-Trimethyldodecane
|
2,6,11-Trimethyldodecane
|
|
C15H32
|
212.250401
|
|
LMFA07010805
|
cis-3-Hexenyl cis-3-hexenoate
|
(3Z)-hex-3-en-1-yl (3Z)-hex-3-enoate
|
WE 12:2
|
C12H20O2
|
196.146330
|
|
LMFA07010805
|
cis-3-Hexenyl cis-3-hexenoate
|
(3Z)-hex-3-en-1-yl (3Z)-hex-3-enoate
|
WE 12:2
|
C12H20O2
|
196.146330
|
|
LMFA03020064
|
20-oxo-leukotriene B4
|
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03020064
|
20-oxo-leukotriene B4
|
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03020064
|
20-oxo-leukotriene B4
|
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03030015
|
Thromboxane
|
(2R,3S)-3-heptyl-2-octyloxane
|
FA 20:0;O
|
C20H40O
|
296.307916
|
|
LMFA03030015
|
Thromboxane
|
(2R,3S)-3-heptyl-2-octyloxane
|
FA 20:0;O
|
C20H40O
|
296.307916
|
|
LMFA01050437
|
11-Hydroxy-9-tridecenoic acid
|
11-Hydroxy-9E-tridecenoic acid
|
FA 13:1;O
|
C13H24O3
|
228.172545
|
|
LMFA01050437
|
11-Hydroxy-9-tridecenoic acid
|
11-Hydroxy-9E-tridecenoic acid
|
FA 13:1;O
|
C13H24O3
|
228.172545
|
|
LMFA13010063
|
1-O-alpha-D-Glucopyranosyl-D-mannitol
|
6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,4,5-pentol
|
|
C12H24O11
|
344.131866
|
|
LMFA05000560
|
(E)-3-Octen-1-ol
|
(3E)-oct-3-en-1-ol
|
FOH 8:1
|
C8H16O
|
128.120115
|
|
LMFA05000576
|
1,17-Heptadecanediol
|
heptadecane-1,17-diol
|
FOH 17:0;O
|
C17H36O2
|
272.271531
|
|
LMFA01120007
|
Dinor-7-NO2-CLA
|
7-nitro-7Z,9E-hexadecadienoic acid
|
|
C16H27NO4
|
297.194009
|
|
LMFA01120007
|
Dinor-7-NO2-CLA
|
7-nitro-7Z,9E-hexadecadienoic acid
|
|
C16H27NO4
|
297.194009
|
|
LMFA01160011
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160011
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160011
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160011
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160011
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1R,2S)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA05000552
|
(2S)-octane-1,2-diol
|
(2S)-octane-1,2-diol
|
FOH 8:0;O
|
C8H18O2
|
146.130680
|
|
LMFA13010059
|
(S)-malyl N-acetyl-alpha-D-glucosaminide
|
(2S)-2-[(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)oxy]butanedioic acid
|
|
C12H19NO10
|
337.100899
|
|
LMFA01050438
|
15-hydroxy-tetracosa-6,9,12,16,18-pentaenoic acid
|
15-hydroxy-6Z,9Z,12Z,16E,18Z-tetracosapentaenoic acid
|
FA 24:5;O
|
C24H38O3
|
374.282096
|
|
LMFA01050438
|
15-hydroxy-tetracosa-6,9,12,16,18-pentaenoic acid
|
15-hydroxy-6Z,9Z,12Z,16E,18Z-tetracosapentaenoic acid
|
FA 24:5;O
|
C24H38O3
|
374.282096
|
|
LMFA07070063
|
Elaidic carnitine
|
3-[(9E)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:1
|
C25H47NO4
|
425.350510
|
|
LMFA07070063
|
Elaidic carnitine
|
3-[(9E)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:1
|
C25H47NO4
|
425.350510
|
|
LMFA07070108
|
Tiglylcarnitine
|
3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 5:1
|
C12H21NO4
|
243.147059
|
|
LMFA07070108
|
Tiglylcarnitine
|
3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 5:1
|
C12H21NO4
|
243.147059
|
|
LMFA07070108
|
Tiglylcarnitine
|
3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 5:1
|
C12H21NO4
|
243.147059
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07050097
|
(15Z)-3-oxotetracosenoyl-CoA
|
3-oxo-15Z-tetracosenoyl-CoA
|
CoA 24:2;O
|
C45H78N7O18P3S
|
1129.433690
|
|
LMFA07010728
|
2-Methylpropyl butanoate
|
2-methylpropyl butanoate
|
WE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA07010728
|
2-Methylpropyl butanoate
|
2-methylpropyl butanoate
|
WE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA07070059
|
Decanoylcarnitine
|
3-(decanoyloxy)-4-(trimethylazaniumyl)butanoate
|
CAR 10:0
|
C17H33NO4
|
315.240959
|
|
LMFA07050307
|
Crotonoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-but-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:1
|
C25H40N7O17P3S
|
835.141424
|